What has been the impact of new drug treatments on epilepsy?

Z Chen, MJ Brodie, P Kwan - Current opinion in neurology, 2020 - journals.lww.com
What has been the impact of new drug treatments on epilepsy? : Current Opinion in Neurology
What has been the impact of new drug treatments on epilepsy? : Current Opinion in Neurology …

Cannabidiol and other cannabinoids in demyelinating diseases

C Navarrete, A García-Martín, A Rolland… - International Journal of …, 2021 - mdpi.com
A growing body of preclinical evidence indicates that certain cannabinoids, including
cannabidiol (CBD) and synthetic derivatives, may play a role in the myelinating processes …

Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes

S Sermet, J Li, A Bach, RB Crawford, NE Kaminski - Toxicology, 2021 - Elsevier
Cannabidiol (CBD) is a major non-euphoric cannabis-derived compound that has become
popular in its over-the-counter use. CBD possesses low affinity for cannabinoid receptors …

[PDF][PDF] Estudio del efecto del cannabidiol en monoterapia o en combinación con antiepilépticos, en la expresión de crisis convulsivas generalizadas recurrentes en …

CL Frías Soria - 2023 - repositorio.cinvestav.mx
La epilepsia es una enfermedad neurológica que afecta a aproximadamente 50 millones de
personas a nivel mundial (World Health Organization, 2019). Este padecimiento se …

Cognitive Functioning in Abstinent Cannabis Users: A Neuropsychological and MEG Investigation

CL Kelly - 2023 - figshare.mq.edu.au
Cannabis is the most commonly used illicit substance worldwide, with an estimated 4% of
the global population using cannabis annually. Considering the increasing legalisation of …